DMR Hydroengineering & Infrastructures Limited Rights Issue 2024
- Published Date: July 08, 2025
- Updated Date: July 09, 2025
- By Team Choice
ar
DMR Hydroengineering & Infrastructures Limited is launching a Rights Issue worth Rs 140 crore, available for subscription from 14 November 2024 to 3 December 2024. Shareholders will be entitled to 1 Rights equity share for every 20 fully paid-up equity shares they own as of the record date, 22 October 2024. Each share has a face value of Rs. 10, and the issue price is set at Rs. 2.66 per share.
Stay tuned with us for comprehensive details on the DMR Hydroengineering & Infrastructures Ltd 2024 Rights Issue, including the issue size, entitlement, payment terms, and more.
DMR Hydroengineering & Infrastructures Limited Rights Issue Of Shares Detail Overview 2024
| Security Name | DMR Hydroengineering & Infrastructures Ltd. |
|---|---|
| Issue Open/Close | November 14, 2024 - December 3, 2024 |
| Record Date | October 22, 2024 |
| Issue Size (Amount) | ₹2.66 Crores |
| Issue Size (Shares) | 189,685 |
| Right Issue Price | ₹140 per share |
| Face Value | ₹10 per share |
| CMP | ₹148 |
| Renunciation of Rights Entitlements | November 25, 2024 |
| Terms of Payment | The Issue Price of Rs. 140/- per Rights Equity Share shall be payable at the time of making the application for Rights Issue. |
| Entitlement | 1 Rights Equity Shares for every 20 fully paid-up Equity Shares held on Record Date. |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. choiceindia.com
Recommended for you
FII DII Data - Live Data
Indian Stock Market Prediction For Next Week
10 Best SIP Plans For ₹1000 Per Month in 2025
Pharma Mutual Funds – Best Option to Invest in 2025?
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.